Marcos Delgado

Dr. Marcos Delgado

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2018 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
THTabea Hutter
Tabea Hutter
DSDirk Springe
Dirk Springe
LELukas Ebnöther
Lukas Ebnöther
MDMarcos Delgado
Marcos Delgado
Cytomegalovirus infection is known to cause symptomatic disease in immunocompromised patients, while an infection in immunocompetent individuals normally causes few or no symptoms. We present the case of an immunocompetent adult patient with unexpected severe evolution. An otherwise healthy, 72-year-old Caucasian woman presented with complaints of progressive shoulder pain and dyspnoea on exertion. The blood test results showed elevated inflammation parameters and elevated hepatic transaminase levels. Radiologic examinations were carried out, and the computed tomography scan revealed a hepatomegaly and a chest X-ray showed evidence of a unilateral pleural effusion. A transthoracic echocardiography detected pericardial effusion with consecutive hemodynamic changes. Since it was considered that using ultrasound-guided pericardiocentesis could significantly increase the risk of liver injury due to hepatomegaly, a pericardial window was performed instead. Further investigation showed that our patient tested positive for an acute cytomegalovirus infection in the serologic tests. Laboratory findings included new evidence of immunoglobulin M seroconversion and high immunoglobulin G avidity, so we considered the possibility that a former cytomegalovirus infection may be coexisting with a new cytomegalovirus reinfection. In immunocompetent individuals, a symptomatic cytomegalovirus primary infection or reinfection should be considered in patients presenting with pericardial effusion and serositis.

9 April 2025 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
MDMarcos Delgado
Marcos Delgado
RSReto A. Schuepbach
Reto A. Schuepbach
JBJan Bartussek
Jan Bartussek
Oxidative stress arises from the excessive production of toxic free radicals, known as reactive oxygen species (ROS), regularly generated as byproducts of mitochondrial ATP production.When the balance between ROS generation and antioxidant defenses, such as glutathione, is disrupted, ROS will accumulate, leading to cellular damage (1). Oxidative stress leads to lipid peroxidation of neuronal membranes, protein damage, and DNA/RNA oxidation, triggering cellular apoptosis and promoting the release of inflammatory cytokines, which play a key role in the pathogenesis of neurocognitive disorders (2). These free radicals cause neuronal protein and genetic dysfunctions, leading to protein aggregation (such as Lewy bodies, amyloid plaques, or neurofibrillary tangles) and iron accumulation in the brain-common pathological features of neurocognitive disorders like Parkinson's disease (PD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and prion diseases (2).Smoking is a major public health concern due to its association with high morbidity and mortality. Numerous studies have demonstrated its strong correlation with cardiovascular, respiratory, and cancer-related diseases, ultimately increasing mortality rates and healthcare costs (3). However, this contrasts with extensive epidemiological research suggesting an inverse correlation between smoking and the incidence of neurodegenerative diseases like PD and AD, while not negating the higher mortality rate among smokers (4,5). This observation suggests that certain compounds in tobacco smoke may offer potential therapeutic benefits.Nicotine is the most abundant and extensively studied components of tobacco. Numerous studies have shown that neurodegenerative diseases are associated with a reduction in nicotinic acetylcholine receptors (nAChRs) (6).Upregulation. Nicotine's interaction with α7 and α4β2-nAChRs, leading to their upregulation and an increase in binding sites, may underlie its neuroprotective effects in patients with PD and AD. This mechanism could contribute to both symptomatic relief and improved cognitive function (7) . Radiological and postmortem studies have shown a reduction in nAChR density in individuals with these neurodegenerative diseases (6,8). These findings support the hypothesis that enhancing nAChR expression, may be one mechanism by which nicotine provides neuroprotection, potentially reducing or delaying disease onset.A substantial body of research has investigated the antioxidant properties of nicotine. Most of these studies are based on preclinical trials at the cellular, molecular, or animal level. However, also clinical, epidemiological, and postmortem studies in humans highlight the significant therapeutic potential of nicotine. A mechanistic biochemical representation of the major nicotine-related pathways that are thought to be involved in reducing oxidative stress is depicted in Figure 1.In 1999, Linert et al. (9) investigated the potential antioxidant actions of nicotine in both in vitro and in vivo models. They analyzed the effect of iron in the substantia nigra pars compacta when combined with hydrogen peroxide (H₂O₂) to induce the Fenton reaction, a process that amplifies oxidative stress and is considered a key mechanism underlying Parkinson's disease.Their results suggest that nicotine can bind iron and potentially reduce its redox activity; however, direct evidence for its inhibition of the Fenton reaction remains limited. Nonetheless, this interaction could represent one pathway through which nicotine exerts antioxidative and, consequently, neuroprotective effects.A study conducted by Guan et al. in 2003 (10) investigated the effects of varying concentrations of nicotine, along with oxidative and antioxidative substances, on the viability of a rat pheochromocytoma cell line. Cell survival was assessed using the MTT assay (3-(4,5methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay), a method that evaluates cellular metabolic activity based on mitochondrial function. A decrease in MTT assay readings was interpreted as indicative of cell destruction through oxidative stress mechanisms. The results demonstrated that cell viability remained stable when exposed to low concentrations of nicotine. In contrast, higher nicotine doses resulted in a reduction in cell survival. But, the coadministration of antioxidants with high nicotine doses mitigated this effect, preserving cell viability at levels comparable to control samples. Similarly, the addition of oxidative agents to the culture, combined with low-dose nicotine, maintained cell viability comparable to that of the control group. The study also explored the impact of amyloid beta peptide (Aβ25-35), a neurotoxic molecule implicated in Alzheimer's disease due to its oxidative properties.Exposure to Aβ25-35 significantly reduced cell viability; however, the administration of lowdose nicotine restored cell survival to normal levels. In contrast, increasing the nicotine dose led to a marked reduction in cell viability. These findings underscore the dual role of nicotine, with low concentrations exerting a protective effect under conditions of oxidative stress, while higher doses are cytotoxic. Dong and collaborators (11) conducted an interesting study evaluating the effect of low-dose nicotine on hippocampal neurons under the hypothesis of a protective effect against Alzheimer's disease. In their research, they demonstrated that nicotine suppresses neuronal damage induced by H₂O₂ in hippocampal cells, reducing the generation of ROS through the activation of α7-nAchR and upregulation of Erk 1 and 2 (extracellular signal-Regulated Kinases 1 and 2), essential in promoting cell survival and proliferation and prevention of apoptosis.Another recent trial conducted by Boiangiu et al (12) using rat models of AD showed that cotinine and 6-hydroxy-L-nicotine, both nicotinic derivatives, improve...

26 May 2020 in Case Reports in Critical Care
Verified
Journal Article
Open access
PDF file
SGS. Guglielmetti
S. Guglielmetti
CJC. M. Jaccard
C. M. Jaccard
KMK. Mühlethaler
K. Mühlethaler
ABA. Bigler
A. Bigler
DSD. Springe
D. Springe
MDMarcos Delgado
Marcos Delgado
Invasive aspergillosis represents a clinical picture frequently associated with hosts immunosuppression which usually involves a high morbidity and mortality. In general, the most frequent fungal entry is the lungs with secondary hematogenous dissemination, but there are other hypotheses like a gastrointestinal portal of entry. There are some rare publications of cases with invasive aspergillosis in immunocompetent patients. We present the case of an immunocompetent patient without any risk factors except for age, ICU stay, and surgical intervention, who developed a septic shock by invasive gastrointestinal aspergillosis as primary infection. Due to the unusualness of the case, despite all the measures taken, the results were obtained postmortem. We want to emphasize the need not to underestimate the possibility for an invasive aspergillosis in an immunocompetent patient. Not only pulmonary but also gastrointestinal aspergillosis should be taken into account in the differential diagnosis to avoid a delay of treatment.

30 November 2018 in Case Reports in Neurology
Verified
Journal Article
Open access
PDF file
MBMathias Bürki
Mathias Bürki
LKLiliane Kappeler
Liliane Kappeler
RBRobert Bühler
Robert Bühler
DSDirk Springe
Dirk Springe
LELukas Ebnöther
Lukas Ebnöther
MDMarcos Delgado
Marcos Delgado
We report of a 75-year-old patient with stroke-like presentation, where cerebral imaging led to the diagnosis of a massive arteriovenous malformation (AVM) of the whole left hemisphere. We suggest considering AVM as a differential diagnosis in patients with symptoms of acute stroke despite age and, in the absence of contraindications, in this setting to obtain MRI or CT angiography of the brain.

11 February 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
MDMarcos Delgado
Marcos Delgado
RFRobert Fritze
Robert Fritze
MHMatthias P. Hilty
Matthias P. Hilty
MKMichael Krauthammer
Michael Krauthammer
RSReto A. Schuepbach
Reto A. Schuepbach
JBJan Bartussek
Jan Bartussek
Oxygen therapy is a cornerstone in the treatment of critically ill patients. However, excess oxygen administration may promote oxidative cellular injury once hemoglobin is fully saturated and additional oxygen remains dissolved, enhancing reactive oxygen species formation. The combined impact of oxygen administration, pH, and respiratory failure on hyperoxemia across saturation ranges is not well understood. We conducted a retrospective study at a tertiary center to assess how these factors modify hyperoxemia frequency in adult ICU patients. Continuous SpO2 measurements were aligned with arterial blood gases (PaO2, pH, FiO2), and hyperoxemia was evaluated using predefined PaO2 thresholds (>120 mmHg and >150 mmHg). Among 21,406 patients with 717,064 paired measurements, prolonged hyperoxemia occurred in over half of mechanically ventilated patients, most commonly in those without or with mild-to-moderate respiratory failure. Acidotic states were associated with higher PaO2 values at comparable SpO2 levels, consistent with a rightward shift in the oxygen–hemoglobin dissociation curve. SpO2 values ≥ 98% were consistently associated with hyperoxemia, whereas 96–97% generally corresponded to PaO2 within physiological ranges. Higher FiO2 markedly increased hyperoxemia probability, allowing derivation of pH-stratified FiO2 exposure limits. Our findings highlight the importance of individualized oxygen therapy, considering pH and respiratory failure phenotype to guide safer oxygen management.

24 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
JBJasmin Bachmann
Jasmin Bachmann
MDMarcos Delgado
Marcos Delgado
RSReto A. Schuepbach
Reto A. Schuepbach
JBJan Bartussek
Jan Bartussek
GSGeorg Ralph Spinner
Georg Ralph Spinner
Delirium is a multifactorial and complex syndrome commonly observed in intensive care unit (ICU) patients, significantly affecting outcomes, mortality, and healthcare costs. Despite numerous potential risk factors, its exact pathophysiology remains unclear. This study explores the use of Additive Bayesian Networks (ABNs) to analyse ICU patient data and identify delirium risk factors. Three cohorts with delirium-related symptoms were examined: general delirium, delirium tremens (DT), and hepatic encephalopathy (HE). Delirium was measured by the Intensive Care Delirium Screening Checklist (ICDSC) whereas the other cohort depend on the coded diagnosis. The analysis shows important connections, such as the two-way link between antipsychotic medication and delirium and the connections of ventilation and age to delirium. Some of the results are in line with research like the link between high levels of ammonia and HE and the strong link between infection, painkillers, and pain that remains the same across all three groups. However, novel insights, such as the reduced likelihood of delirium (ICDSC ≥4) with age and ventilation, challenge conventional understanding. This study shows how ABNs can be used to find complicated dependencies in the ICU. Future work should focus on addressing potential overfitting or unmodeled interactions in the dataset and exploring specific delirium subtypes, such as hypoactive and hyperactive delirium.